Eric Weisblum
Chairman, President & CEOMr. Eric Weisblum serves as Independent Director at Change Agents Corporation since October 12, 2026. He has been the Chief Executive Officer and Chairman of the Board of Silo Pharma, Inc. (formerly known as, Uppercut Brands Inc.) since November 27, 2015 and has been its President and Director since January 28, 2013. Mr. Weisblum had been Chief Financial Officer of Silo Pharma, Inc. (formerly known as Uppercut Brands Inc.) since May 31, 2018 until September 27, 2022. He is the founder of Silo Pharma Inc. He co-founded Whalehaven Capital in 2003. He is Partner of Whalehaven Capital's General Partner and Managing Member of JAWS Capital Partners, LLC. From 2002 to 2003, he was a registered representative with Domestic Securities. While with Domestic Securities, Mr. Weisblum held the Series 7 - General Securities Representative, the Series 63 Uniform Securities Agent State Law Examination and the Series 55 Registered Equity Trader securities registrations. From 1993 to 2002, Mr. Weisblum originated, structured, traded and placed structured financing transactions at M.H. Meyerson & Co. Inc. (“M.H”). He had been Independent Director of AIkido Pharma Inc. (formerly known as Spherix Incorporated) since August 24, 2016 and Earth Brand Holdings, Inc. since December 18, 2013. He holds a Bachelor of Arts degree from the University of Hartford's Barney Business School.
Positions
- Company NameSilo Pharma, Inc.Stock CodeSILOPositionChairman, President & CEO
- Company NameChange Agents CorporationStock CodeCHGAPositionIndependent Director
